Purchase Order 75N91019P00499

<p>The National Cancer Institute issued a purchase order to Nanostring Technologies, Inc. valued at $24,750.00 on January 9, 2020 for laboratory testing and service. Performance occurs in Bethesda, Maryland with an ultimate completion date of February 29, 2020. The order covers specialized laboratory equipment, reagents, assays, or testing services in support of genomic, molecular, and cellular analysis for biomedical research. No set-aside category applies.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for $24,150.00 on September 3, 2020, with an ultimate completion date of October 2, 2020. The order covers biological kits on a firm fixed price basis. Work is performed in Seattle, Washington. No set-aside category applies to this award.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc., for $19,000 on July 6, 2017, covering quarterly in-arrears service for an nCounter Digital Analyzer and Prep Station. Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of July 26, 2018. No small business set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. valued at $22,388.00 for drugs and biologicals, effective September 16, 2020, with completion by October 31, 2020. Place of performance is Seattle, Washington. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute issued a purchase order to Nanostring Technologies, Inc. on August 31, 2020, valued at $17,125.00 for drugs and biologicals. Work is performed in Seattle, Washington. The order carries a firm fixed price and was designated under the Coronavirus COVID-19 National Interest Action Code. Ultimate completion is scheduled for September 30, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for biological kits valued at $23,204.00, with an award date of May 18, 2021 and ultimate completion date of June 17, 2021. Place of performance is Seattle, Washington. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc. for biological kits valued at $22,160.00 on April 8, 2021, with ultimate completion on May 7, 2021. Place of performance is Seattle, Washington. The order is for specialized laboratory reagents and consumables to support genomic and molecular analysis research.</p>

<p>The National Cancer Institute awarded a purchase order to Nanostring Technologies, Inc., for biological kits valued at $22,867.85 on September 17, 2020, with completion by October 17, 2020. Work is performed in Seattle, Washington. The order is designated as a firm fixed price acquisition in response to the Coronavirus COVID-19 national interest action. No small business set-aside applies.</p>

The National Cancer Institute awarded Nanostring Technologies, Inc. a $5,974.50 firm fixed price call against a blanket purchase agreement for biological materials, chemicals, and laboratory supplies on April 17, 2018. The contract, which was not set aside for small businesses, represents a delivery order for specialized genomic analysis consumables and reagents to support the National Cancer Institute's research initiatives. The work was completed by May 17, 2018, with performance taking...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,741 purchase order to Nanostring Technologies, Inc. of Seattle, Washington for reagents. The firm fixed price contract runs from August 25, 2023 through September 25, 2023 and supports the NIH NCI's research efforts. As a leading provider of life science tools for translational research and molecular diagnostic products, Nanostring will deliver the requested reagents to aid in the...